Which stocks are most active on Tuesday?
By Mill Chart
Last update: Oct 4, 2022
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
Top most active stocks
| Ticker | Change | Comment |
|---|---|---|
| BTB | 161.0% | BIT BROTHER LTD's (NASDAQ:BTB) traded a high volume of 161.2M shares. NASDAQ:BTB is advancing 161.0% today. |
| CCL | 13.03% | 84.19M shares of CARNIVAL CORP (NYSE:CCL) exchanged hands today. NYSE:CCL is advancing 13.03% today. |
| TSLA | 1.27% | So far 80.81M shares of TESLA INC (NASDAQ:TSLA) have traded in today's session. Leading to a price increase of 1.27%. |
| HGEN | 7.87% | HUMANIGEN INC's (NASDAQ:HGEN) traded a high volume of 69.9M shares. Leading to a price increase of 7.87%. A press release (Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm) was released two days ago. |
| F | 6.55% | So far 59.02M shares of FORD MOTOR CO (NYSE:F) have traded in today's session. Shares are rising by 6.55%. A press release (Ford EV Sales Triple in Sept.; Continues As America’s No. 2 EV Brand, Mustang Mach-E Climbs 47%; F-Series, Transit Vans Rank First in Both Gas And Electric; Bronco Sales More Than Triple) was released earlier today. |
| AMD | 2.3% | ADVANCED MICRO DEVICES's (NASDAQ:AMD) traded a high volume of 54.51M shares. Shares are rising by 2.3%. |
| AAPL | 1.63% | 53.97M shares of APPLE INC (NASDAQ:AAPL) have been traded so far today. Shares are rising by 1.63%. |
| MULN | 8.55% | So far 50.01M shares of MULLEN AUTOMOTIVE INC (NASDAQ:MULN) have traded in today's session. The share price increased by 8.55%. |
| SNTI | 57.6% | SENTI BIOSCIENCES INC's (NASDAQ:SNTI) traded a high volume of 44.32M shares. NASDAQ:SNTI is advancing 57.6% today. |
| AERC | 60.75% | So far 43.94M shares of AEROCLEAN TECHNOLOGIES INC (NASDAQ:AERC) have traded in today's session. Leading to a price increase of 60.75%. Earlier today the company had a press release: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Poshmark, Inc. (Nasdaq – POSH), First Eagle Alternative Capital BDC, Inc. (Nasdaq – FCRD), AeroClean Technologies (Nasdaq – AERC), Talos Energy Inc. (NYSE - TALO). |
Our most active stocks screener will show you the full list.
SENTI BIOSCIENCES INC
NASDAQ:SNTI (5/1/2024, 4:28:25 PM)
After market: 0.38 0 (0%)0.38
+0.02 (+5.56%)
SNTI News
a day ago - Senti Biosciences, Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)Senti Bio today announced the publication of preclinical data that supports the design of the Phase 1 clinical trial of SENTI-202....
a month ago - InvestorPlaceSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.
a month ago - BusinessInsiderSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...
a month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...
4 months ago - Seeking AlphaSenti Biosciences to reduce workforce by 37% (NASDAQ:SNTI)Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.
4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...
4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...
5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayChecking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
